A novel nomogram based on cell cycle-related genes for predicting overall survival in early-onset colorectal cancer

Abstract Background Although the incidence of late-onset colorectal cancer (LOCRC) has decreased, the incidence of early-onset colorectal cancer (EOCRC) is still rising dramatically. Heterogeneity in the genomic, biological, and clinicopathological characteristics between EOCRC and LOCRC has been re...

Full description

Bibliographic Details
Main Authors: Meijuan Xiang, Yuan Gao, Yue Zhou, Muqing Wang, Xueqing Yao
Format: Article
Language:English
Published: BMC 2023-06-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-023-11075-y
_version_ 1827910756764483584
author Meijuan Xiang
Yuan Gao
Yue Zhou
Muqing Wang
Xueqing Yao
author_facet Meijuan Xiang
Yuan Gao
Yue Zhou
Muqing Wang
Xueqing Yao
author_sort Meijuan Xiang
collection DOAJ
description Abstract Background Although the incidence of late-onset colorectal cancer (LOCRC) has decreased, the incidence of early-onset colorectal cancer (EOCRC) is still rising dramatically. Heterogeneity in the genomic, biological, and clinicopathological characteristics between EOCRC and LOCRC has been revealed. Therefore, the previous prognostic models based on the total CRC patient population might not be suitable for EOCRC patients. Here, we constructed a prognostic classifier to enhance the precision of individualized treatment and management of EOCRC patients. Methods EOCRC expression data were downloaded from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases. The regulatory pathways were explored by gene set enrichment analysis (GSEA). The prognostic model was developed by univariate Cox-LASSO-multivariate Cox regression analyses of GEO samples. TCGA samples were used to verify the model. The expression and mutation profiles and immune landscape of the high-risk and low-risk cohorts were analyzed and compared. Finally, the expression and prognostic value of the model genes were verified by immunohistochemistry and qRT‒PCR analysis. Results The cell cycle was identified as the most significantly enriched oncological signature of EOCRC. Then, a 4-gene prognostic signature comprising MCM2, INHBA, CGREF1, and KLF9 was constructed. The risk score was an independent predictor of overall survival. The area under the curve values of the classifier for 1-, 3-, and 5-year survival were 0.856, 0.893, and 0.826, respectively, in the training set and 0.749, 0.858, and 0.865, respectively, in the validation set. Impaired DNA damage repair capability (p < 0.05) and frequent PIK3CA mutations (p < 0.05) were found in the high-risk cohort. CD8 T cells (p < 0.05), activated memory CD4 T cells (p < 0.01), and activated dendritic cells (p < 0.05) were clustered in the low-risk group. Finally, we verified the expression of MCM2, INHBA, CGREF1, and KLF9. Their prognostic value was closely related to age. Conclusion In this study, a robust prognostic classifier for EOCRC was established and validated. The findings may provide a reference for individualized treatment and medical decision-making for patients with EOCRC.
first_indexed 2024-03-13T01:54:08Z
format Article
id doaj.art-0ea19279a1f041dda573b5151297d771
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-03-13T01:54:08Z
publishDate 2023-06-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-0ea19279a1f041dda573b5151297d7712023-07-02T11:18:24ZengBMCBMC Cancer1471-24072023-06-0123111910.1186/s12885-023-11075-yA novel nomogram based on cell cycle-related genes for predicting overall survival in early-onset colorectal cancerMeijuan Xiang0Yuan Gao1Yue Zhou2Muqing Wang3Xueqing Yao4School of Medicine, South China University of TechnologyDepartment of Gastrointestinal Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical SciencesDepartment of Gastrointestinal Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical SciencesSchool of Medicine, South China University of TechnologySchool of Medicine, South China University of TechnologyAbstract Background Although the incidence of late-onset colorectal cancer (LOCRC) has decreased, the incidence of early-onset colorectal cancer (EOCRC) is still rising dramatically. Heterogeneity in the genomic, biological, and clinicopathological characteristics between EOCRC and LOCRC has been revealed. Therefore, the previous prognostic models based on the total CRC patient population might not be suitable for EOCRC patients. Here, we constructed a prognostic classifier to enhance the precision of individualized treatment and management of EOCRC patients. Methods EOCRC expression data were downloaded from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases. The regulatory pathways were explored by gene set enrichment analysis (GSEA). The prognostic model was developed by univariate Cox-LASSO-multivariate Cox regression analyses of GEO samples. TCGA samples were used to verify the model. The expression and mutation profiles and immune landscape of the high-risk and low-risk cohorts were analyzed and compared. Finally, the expression and prognostic value of the model genes were verified by immunohistochemistry and qRT‒PCR analysis. Results The cell cycle was identified as the most significantly enriched oncological signature of EOCRC. Then, a 4-gene prognostic signature comprising MCM2, INHBA, CGREF1, and KLF9 was constructed. The risk score was an independent predictor of overall survival. The area under the curve values of the classifier for 1-, 3-, and 5-year survival were 0.856, 0.893, and 0.826, respectively, in the training set and 0.749, 0.858, and 0.865, respectively, in the validation set. Impaired DNA damage repair capability (p < 0.05) and frequent PIK3CA mutations (p < 0.05) were found in the high-risk cohort. CD8 T cells (p < 0.05), activated memory CD4 T cells (p < 0.01), and activated dendritic cells (p < 0.05) were clustered in the low-risk group. Finally, we verified the expression of MCM2, INHBA, CGREF1, and KLF9. Their prognostic value was closely related to age. Conclusion In this study, a robust prognostic classifier for EOCRC was established and validated. The findings may provide a reference for individualized treatment and medical decision-making for patients with EOCRC.https://doi.org/10.1186/s12885-023-11075-yYoung-onset colorectal cancerCell cyclePrognostic indicatorIndividualized treatment
spellingShingle Meijuan Xiang
Yuan Gao
Yue Zhou
Muqing Wang
Xueqing Yao
A novel nomogram based on cell cycle-related genes for predicting overall survival in early-onset colorectal cancer
BMC Cancer
Young-onset colorectal cancer
Cell cycle
Prognostic indicator
Individualized treatment
title A novel nomogram based on cell cycle-related genes for predicting overall survival in early-onset colorectal cancer
title_full A novel nomogram based on cell cycle-related genes for predicting overall survival in early-onset colorectal cancer
title_fullStr A novel nomogram based on cell cycle-related genes for predicting overall survival in early-onset colorectal cancer
title_full_unstemmed A novel nomogram based on cell cycle-related genes for predicting overall survival in early-onset colorectal cancer
title_short A novel nomogram based on cell cycle-related genes for predicting overall survival in early-onset colorectal cancer
title_sort novel nomogram based on cell cycle related genes for predicting overall survival in early onset colorectal cancer
topic Young-onset colorectal cancer
Cell cycle
Prognostic indicator
Individualized treatment
url https://doi.org/10.1186/s12885-023-11075-y
work_keys_str_mv AT meijuanxiang anovelnomogrambasedoncellcyclerelatedgenesforpredictingoverallsurvivalinearlyonsetcolorectalcancer
AT yuangao anovelnomogrambasedoncellcyclerelatedgenesforpredictingoverallsurvivalinearlyonsetcolorectalcancer
AT yuezhou anovelnomogrambasedoncellcyclerelatedgenesforpredictingoverallsurvivalinearlyonsetcolorectalcancer
AT muqingwang anovelnomogrambasedoncellcyclerelatedgenesforpredictingoverallsurvivalinearlyonsetcolorectalcancer
AT xueqingyao anovelnomogrambasedoncellcyclerelatedgenesforpredictingoverallsurvivalinearlyonsetcolorectalcancer
AT meijuanxiang novelnomogrambasedoncellcyclerelatedgenesforpredictingoverallsurvivalinearlyonsetcolorectalcancer
AT yuangao novelnomogrambasedoncellcyclerelatedgenesforpredictingoverallsurvivalinearlyonsetcolorectalcancer
AT yuezhou novelnomogrambasedoncellcyclerelatedgenesforpredictingoverallsurvivalinearlyonsetcolorectalcancer
AT muqingwang novelnomogrambasedoncellcyclerelatedgenesforpredictingoverallsurvivalinearlyonsetcolorectalcancer
AT xueqingyao novelnomogrambasedoncellcyclerelatedgenesforpredictingoverallsurvivalinearlyonsetcolorectalcancer